Veradigm (MDRX) News Today $4.40 +0.25 (+6.02%) As of 04/24/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Veradigm Extends Interim CFO Tenure Amid Leadership ChangesApril 22 at 5:14 PM | tipranks.comVeradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.comStockNews.com assumed coverage on Veradigm in a research note on Friday. They set a "hold" rating for the company.April 20, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.comStockNews.com began coverage on shares of Veradigm in a research note on Thursday. They issued a "hold" rating for the company.April 12, 2025 | marketbeat.comBlack Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025April 9, 2025 | businesswire.comBlack Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025April 9, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Now Covered by StockNews.comStockNews.com started coverage on Veradigm in a research note on Wednesday. They set a "hold" rating for the company.April 3, 2025 | marketbeat.comSyracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational EfficiencyApril 2, 2025 | businesswire.comVeradigm price target lowered to $5 from $9 at Deutsche BankMarch 27, 2025 | markets.businessinsider.comVeradigm (NASDAQ:MDRX) Shares Gap Up - What's Next?Veradigm (NASDAQ:MDRX) Shares Gap Up - Still a Buy?March 22, 2025 | marketbeat.comVeradigm updates shareholder rights agreementMarch 20, 2025 | uk.investing.comVeradigm Inc. (MDRX) Investor Update Call TranscriptMarch 19, 2025 | seekingalpha.comVeradigm Announces Appointment of Two New Independent Directors and Transition of Board LeadershipMarch 18, 2025 | tmcnet.comVeradigm Files Fiscal 2022 Form 10-K and Restated Financial StatementsMarch 18, 2025 | businesswire.comVeradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025March 18, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Shares Down 4.8% - Here's WhyVeradigm (NASDAQ:MDRX) Stock Price Down 4.8% - Should You Sell?March 18, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Here's WhyVeradigm (NASDAQ:MDRX) Shares Gap Up - Here's What HappenedMarch 15, 2025 | marketbeat.comVeradigm to Release Financial Update March 18th and Host Investor Call March 19thMarch 13, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Shares Gap Down - What's Next?Veradigm (NASDAQ:MDRX) Shares Gap Down - Here's WhyMarch 13, 2025 | marketbeat.comOver 3,500 Healthcare Practices Receive Gaps-in-Care Alerts at the Point-of-Care via Veradigm Payer Insights SolutionMarch 11, 2025 | finance.yahoo.comVeradigm (NASDAQ:MDRX) Shares Up 9.6% - Time to Buy?Veradigm (NASDAQ:MDRX) Trading 9.6% Higher - Should You Buy?March 11, 2025 | marketbeat.comStockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)StockNews.com initiated coverage on Veradigm in a research note on Sunday. They set a "hold" rating for the company.March 9, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Stock Price Up 4% - Here's WhyVeradigm (NASDAQ:MDRX) Stock Price Up 4% - Should You Buy?March 5, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Down - Should You Sell?Veradigm (NASDAQ:MDRX) Shares Gap Down - Time to Sell?March 4, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Sets New 1-Year Low - What's Next?Veradigm (NASDAQ:MDRX) Sets New 12-Month Low - Here's What HappenedMarch 1, 2025 | marketbeat.comVeradigm Becomes First EHR Media Platform to Achieve POCMA CertificationFebruary 27, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Time to Buy?Veradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy?February 26, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Up 4.9% - Still a Buy?Veradigm (NASDAQ:MDRX) Stock Price Up 4.9% - Should You Buy?February 24, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy?Veradigm (NASDAQ:MDRX) Shares Gap Up - Time to Buy?February 21, 2025 | marketbeat.comStockNews.com Begins Coverage on Veradigm (NASDAQ:MDRX)StockNews.com initiated coverage on shares of Veradigm in a research report on Friday. They set a "hold" rating for the company.February 21, 2025 | marketbeat.comVeradigm Announces Board Expansion and ChangesFebruary 20, 2025 | finance.yahoo.comVeradigm Expands Board with Strategic AppointmentsFebruary 20, 2025 | tipranks.comVeradigm agrees to board refreshment in settlement with Kent Lake CapitalFebruary 20, 2025 | reuters.comVeradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World ResearchFebruary 18, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Still a Buy?Veradigm (NASDAQ:MDRX) Shares Gap Up - Still a Buy?February 11, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Down 4.7% - Should You Sell?Veradigm (NASDAQ:MDRX) Trading Down 4.7% - Time to Sell?February 10, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Shares Gap Up - Here's What HappenedVeradigm (NASDAQ:MDRX) Shares Gap Up - Here's What HappenedFebruary 5, 2025 | marketbeat.comBlack Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care PracticesFebruary 3, 2025 | finance.yahoo.comVeradigm (NASDAQ:MDRX) Shares Gap Down - Here's WhyVeradigm (NASDAQ:MDRX) Shares Gap Down - Should You Sell?February 3, 2025 | marketbeat.comVeradigm stock tumbles after strategic review ends without agreementFebruary 1, 2025 | msn.comVeradigm ends exploration of strategic alternatives without dealJanuary 31, 2025 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on Veradigm (MDRX)January 31, 2025 | markets.businessinsider.comVeradigm stock tumbles as strategic review ends without a dealJanuary 31, 2025 | msn.comVeradigm (NASDAQ:MDRX) Hits New 1-Year Low - What's Next?Veradigm (NASDAQ:MDRX) Reaches New 52-Week Low - What's Next?January 31, 2025 | marketbeat.comStephens Boosts Veradigm (NASDAQ:MDRX) Price Target to $13.00Stephens upped their price target on Veradigm from $7.00 to $13.00 and gave the stock an "equal weight" rating in a research note on Friday.January 31, 2025 | marketbeat.comVeradigm Announces the Resignation of Board Director Beth Altman Due to Health ReasonsJanuary 31, 2025 | finance.yahoo.comVeradigm Ends Business Review Process on Lack of Final BidsJanuary 31, 2025 | marketwatch.comVeradigm ends strategic review after no firm bidsJanuary 31, 2025 | msn.comVeradigm Concludes Exploration of Strategic Alternatives and Announces Operational ReviewJanuary 30, 2025 | businesswire.comVeradigm (NASDAQ:MDRX) Stock Price Down 5% - What's Next?Veradigm (NASDAQ:MDRX) Trading Down 5% - What's Next?January 29, 2025 | marketbeat.comVeradigm (NASDAQ:MDRX) Trading 19.7% Higher - Still a Buy?Veradigm (NASDAQ:MDRX) Trading Up 19.7% - Time to Buy?January 28, 2025 | marketbeat.com Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address MDRX Media Mentions By Week MDRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDRX News Sentiment▼0.580.79▲Average Business Services News Sentiment MDRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDRX Articles This Week▼22▲MDRX Articles Average Week Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Omnicell News Today HealthStream News Today Pony AI News Today NetScout Systems News Today Verint Systems News Today Simulations Plus News Today Ribbon Communications News Today OneSpan News Today ECARX News Today Unisys News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDRX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDRX Stock Free MDRX Stock Alerts